Lv1
48 积分 2024-09-01 加入
Loss of CDKN2A Enhances the Efficacy of Immunotherapy in EGFR-Mutant Non-Small Cell Lung Cancer
1个月前
已完结
Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity
1个月前
已完结
Loss of AXIN1 regulates response to lenvatinib through a WNT/KDM5B/p15 signalling axis in hepatocellular carcinoma
3个月前
已完结
Identification of an m6A Natural Inhibitor, Lobeline, That Reverses Lenvatinib Resistance in Hepatocellular Tumors
5个月前
已完结
Reserpine, a novel N6-methyladenosine regulator, reverses Lenvatinib resistance in hepatocellular carcinoma
5个月前
已完结
PD-L2 drives resistance to EGFR-TKIs: dynamic changes of the tumor immune environment and targeted therapy
6个月前
已完结
Epigenetic enzyme mutations as mediators of anti-cancer drug resistance
6个月前
已完结
Humanized mouse models for immuno-oncology research
6个月前
已完结
皖公网安备34019202002308
